Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001213900-17-007976
Filing Date
2017-07-27
Accepted
2017-07-27 16:28:16
Documents
3

Document Format Files

Seq Description Document Type Size
1 f424b5022717_actiniumphar.htm 424B5 858059
2 GRAPHIC image001.jpg GRAPHIC 35695
3 GRAPHIC image002.jpg GRAPHIC 27209
  Complete submission text file 0001213900-17-007976.txt   946048
Mailing Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016
Business Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016 646-677-3875
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-194768 | Film No.: 17986641
SIC: 2834 Pharmaceutical Preparations